Q3’s biggest healthcare deals: mRNA, digital care and cybersecurity

Becker's Healthcare October 14, 2021
Katie Adams

The biggest healthcare deals in the third quarter of 2021 were for companies focused on mRNA drug discovery, digital care and cybersecurity, according to CB Insights’ third-quarter venture capital report.

Here are the 10 biggest healthcare deals in 2021’s third quarter:

1. Chinese mRNA drugmaker Abogen raised $700 million in a series C funding round.
2. Cambridge, Mass.-based mRNA drugmaker Laronde raised $440 million in a series B funding round.
3. Columbus, Ohio-based healthcare automation company Olive raised $400 million in a series H funding round.
4. Chinese artificial intelligence drug discovery company XtalPi raised $400 million in a series...

Today's Sponsors

Today's Sponsor